James Parsons
Director/Board Member at DIAMEDICA THERAPEUTICS INC.
Net worth: 239 986 $ as of 29/04/2024
Network origin in James Parsons first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Biotechnology | 31 | |
| Public Company | Pharmaceuticals: Major | 26 | |
| Public Company | Biotechnology | 23 | |
Trillium Therapeutics, Inc. /Old/
 Trillium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Trillium Therapeutics Inc. (TTI), is a biopharmaceutical company specializing in the development of innovative therapies for the treatment of immune-mediated disorders. The Company's therapeutic approaches are aimed at restoring balance to the immune system in conditions associated with aberrant or harmful immune responses, such as autoimmune disease, inflammatory disorders, and cancer. TTI's objective is to create a broad and innovative pipeline of proprietary biologic product opportunities, as part of its overall strategy of building and solidifying its reputation as a premier R & D company. The company's business model is to identify therapeutic candidates that have shown promise in animal models and to rapidly advance these into clinical testing. TTI is concentrating its efforts on preclinical and early clinical drug development, with the primary objective of demonstrating safety and proof-of-principle in man. The company has chosen to establish development partnerships for some of its projects at a preclinical stage, and anticipates advancing several others into clinical development on its own. TTI has five scientific programs at various stages of preclinical testing. Two of its programs focus on the immunoregulatory protein CD200 and its receptor, a third targets the activating Fc receptor Fc RIIa (CD32a) and the final two involve the use of a growth factor in the prevention of necrotizing enterocolitis and the treatment of interstitial cystitis.
13
| Extinct | Miscellaneous Commercial Services | 13 |
| Public Company | Biotechnology | 12 | |
| Public Company | Biotechnology | 12 | |
| Public Company | Pharmaceuticals: Major | 6 | |
| Public Company | Metal Fabrication | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to James Parsons via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Toronto | College/University | Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree Graduate Degree | |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Chief Tech/Sci/R&D Officer | |
| The University of Waterloo | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
| University of British Columbia | College/University | Doctorate Degree Masters Business Admin Undergraduate Degree Doctorate Degree | |
| SEAGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Director/Board Member | |
| McMaster University | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| University of Calgary | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of Western Ontario | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| NYMOX PHARMACEUTICAL CORPORATION | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| WI2WI CORPORATION | Telecommunications Equipment | Director/Board Member Chairman | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Graduate Degree | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
| The Aliments Soyummi, Inc. | Director/Board Member Chairman | ||
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
| TYHEE GOLD CORP. | Precious Metals | Director/Board Member Director/Board Member | |
Washington National Opera
 Washington National Opera Movies/EntertainmentConsumer Services Washington National Opera operates as an opera company. The company was founded in 1956 and is headquartered in Washington, DC. | Movies/Entertainment | President Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Simon Fraser University | College/University | Masters Business Admin Corporate Officer/Principal | |
Wi2Wi, Inc.
 Wi2Wi, Inc. Specialty TelecommunicationsCommunications Wi2Wi, Inc. provides advanced microsystems, miniaturized embedded wireless connectivity solutions. Its products include wireless connectivity, timing and frequency control, and antennas and connectors. The company is headquartered in San Jose, CA. | Specialty Telecommunications | Director/Board Member Chairman | |
| Stanford University | College/University | Doctorate Degree Corporate Officer/Principal | |
| McGill University | College/University | Doctorate Degree Corporate Officer/Principal | |
| Boston College | College/University | Undergraduate Degree Undergraduate Degree | |
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| TESARO INC | Pharmaceuticals: Major | General Counsel Director/Board Member | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
Lions Capital Corp.
 Lions Capital Corp. Investment ManagersFinance Lions Capital Corp (Lions Capital) is a fund management and corporate advisory firm founded in 2003. The firm headquartered in Vancouver, Canada. | Investment Managers | Chairman Chief Executive Officer | |
| SANOFI | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Corvita Corp.
 Corvita Corp. Medical SpecialtiesHealth Technology Corvita Corporation is a development stage company engaged primarily in research and development of new medical devices and related biomaterials for treatment of late stage vascular disease. The company is sponsoring two FDA controlled, randomized prospective trials in the US for its peripheral grafts and AV access grafts, both of which are approved for sale in the European Common Market. In addition, Corvita is conducting clinical tests in Europe and plans to begin FDA controlled clinical studies in the US of the Corvita Endoluminal Graft, a new less invasive product for lower cost treatment of vascular trauma, vascular occlusive disease and aneurysmal disease. The majority of the company's activities in FY 96 will be focused on development and testing of Corvita Endoluminal Grafts. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
BC Advantage Funds Ltd.
 BC Advantage Funds Ltd. Investment ManagersFinance Founded 2003, BC Advantage Funds (VCC) Ltd is a venture capital firm, headquartered in Canada. | Investment Managers | Chairman Private Equity Investor | |
| University of California, Los Angeles | College/University | Masters Business Admin Corporate Officer/Principal | |
| University of Michigan | College/University | Masters Business Admin Graduate Degree | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree | |
| REPLIMUNE GROUP, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin Masters Business Admin | |
Williams Creek Gold Ltd.
 Williams Creek Gold Ltd. Precious MetalsNon-Energy Minerals Williams Creek Gold Ltd. engages in the exploration of mineral properties. The company was founded on June 19, 1946 and is headquartered in Vancouver, Canada. | Precious Metals | Chairman Chief Executive Officer | |
| Max-Planck-Institute for Molecular Genetics | College/University | Doctorate Degree Corporate Officer/Principal |
Statistics
International
| United States | 31 |
| Canada | 17 |
| United Kingdom | 2 |
| Bahamas | 2 |
| France | 2 |
Sectoral
| Consumer Services | 22 |
| Health Technology | 20 |
| Finance | 4 |
| Non-Energy Minerals | 3 |
| Electronic Technology | 2 |
Operational
| Director/Board Member | 429 |
| Corporate Officer/Principal | 236 |
| Independent Dir/Board Member | 131 |
| Chairman | 113 |
| President | 90 |
Most connected contacts
| Insiders | |
|---|---|
| Calvin Stiller | 38 |
| Michael R. Sonnenreich | 31 |
| Frank Holler | 29 |
| Hans P. Black | 26 |
| Catherine Mackey | 24 |
| Bernd Seizinger | 23 |
| Richard Kuntz | 23 |
| Leonard Kruimer | 22 |
| Mohammad Azab | 21 |
| Richard Pilnik | 20 |
| Jeffrey Bacha | 20 |
| Michael Berendt | 20 |
| Luke Beshar | 19 |
| Don B. Rix | 18 |
| Michael Giuffre | 18 |
- Stock Market
- Insiders
- James Parsons
- Company connections
